Akihito Kiguchiya

Title: Akihito Kiguchiya: Innovator in Oncology

Introduction

Akihito Kiguchiya is a notable inventor based in Nara, Japan. He has made significant contributions to the field of oncology through his innovative work on AXL kinase inhibitors. With a total of two patents to his name, Kiguchiya's research focuses on therapeutic applications for treating solid tumors and hematopoietic cancers.

Latest Patents

Kiguchiya's latest patents include advancements in AXL kinase inhibitors. These patents detail the tartrate salts of a specific compound structure, along with crystalline forms and their therapeutic applications for treating advanced solid tumors and hematopoietic cancers. Additionally, the patents provide methods for synthesizing these tartrate salts and crystalline forms, showcasing Kiguchiya's commitment to advancing cancer treatment.

Career Highlights

Throughout his career, Akihito Kiguchiya has worked with prominent companies in the pharmaceutical industry, including Sumitomo Dainippon Pharma Oncology, Inc. and Sumitomo Pharma Oncology, Inc. His work in these organizations has allowed him to contribute to significant advancements in cancer therapies.

Collaborations

Kiguchiya has collaborated with notable colleagues such as Adam Siddiqui-Jain and Paul Flynn. These partnerships have further enriched his research and development efforts in the field of oncology.

Conclusion

Akihito Kiguchiya's innovative work in the development of AXL kinase inhibitors represents a significant advancement in cancer treatment. His contributions through patents and collaborations highlight his dedication to improving therapeutic options for patients facing solid tumors and hematopoietic cancers.